Norway· NO-ID_54AEC5EA-8664-4CB9-996B-8AFCB08A0090

Methazolamide

A methazolamide product containing metazolamid, registered in Norway by Lederle (2). The same ATC class is registered in 3 of our 19 countries.

ATC S01EC05

Checked against FEST (Norway) on

Informational only — not a medical device.

SOURCE REGISTER · NOFEST (Norway)normalisedMethazolamideATCS01EC05REGISTER NO.NO-ID_54AEC5EA-8664-4…PACKS LISTED2CHECKEDSeptember 25, 2026

Where it is registered

Methazolamide is registered in 3 of 19 countries.

Countries holding a registration under ATC S01EC05 (methazolamide), each read from that country’s own register.

  • This record: Norway, from FEST (Norway)
  • 2 of them publish a price we can compare per daily dose

Methazolamide · ATC S01EC05

3 / 19 countries

  • Canada
  • Norwayprice
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FEST (Norway)
Active substance
Metazolamid
Manufacturer
Lederle (2)
Country
Norway (NO)
ATC code
S01EC05
ATC class
Methazolamide
Defined daily dose
0.2 g, O
Reimbursed
Not published by this register
Source register
FEST (Norway)
Last checked
September 25, 2026

Packs & prices · 2

  • no_merkevare_id
    ID_54AEC5EA-8664-4CB9-996B-8AFCB08A0090
  • no_varenummer
    267577
    100

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

138 interactions on record for methazolamide.

Graded by severity as the source publishes them — 7 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Methazolamide · interactions on record

138 records

  • 7 severe
  • 126 moderate
  • 5 minor

Most severe, free to view

  • CisaprideA03FA02severe
  • MetforminA10BA02severe
  • Acetylsalicylic acidB01AC06severe
  • Salicylic acidD01AE12severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Methazolamide in 2 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All methazolamide products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FEST (Norway). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/8011814e-3a7d-4da1-b2fc-31a4d1b1d789
GET /v1/drugs/8011814e-3a7d-4da1-b2fc-31a4d1b1d789?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tablett",
  "source": "fest",
  "status": "A",
  "atc_name": "Metazolamid",
  "merkevare_id": "ID_54AEC5EA-8664-4CB9-996B-8AFCB08A0090",
  "name_form_strength": "Methazolamide tab 50 mg",
  "prescription_group": "C"
}

See everything about methazolamide.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.